{"nct_id":"NCT02551159","title":"Phase III Open Label Study of MEDI 4736 With/Without Tremelimumab Versus Standard of Care (SOC) in Recurrent/Metastatic Head and Neck Cancer","status":"COMPLETED","status_verified_date":"2021-09","start_date":"2015-10-15","start_date_type":"ACTUAL","primary_completion_date":"2020-07-06","primary_completion_date_type":"ACTUAL","completion_date":"2021-05-21","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["AZN"]}